These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Use of prostaglandin E1 for prevention of liver veno-occlusive disease in leukaemic patients treated by allogeneic bone marrow transplantation. Gluckman E, Jolivet I, Scrobohaci ML, Devergie A, Traineau R, Bourdeau-Esperou H, Lehn P, Faure P, Drouet L. Br J Haematol; 1990 Mar; 74(3):277-81. PubMed ID: 2159315 [Abstract] [Full Text] [Related]
6. Retrospective multivariate analysis of hepatic veno-occlusive disease after blood or marrow transplantation: possible beneficial use of low molecular weight heparin. Simon M, Hahn T, Ford LA, Anderson B, Swinnich D, Baer MR, Bambach B, Bernstein SH, Bernstein ZP, Czuczman MS, Slack JL, Wetzler M, Herzig G, Schriber J, McCarthy PL. Bone Marrow Transplant; 2001 Mar; 27(6):627-33. PubMed ID: 11319593 [Abstract] [Full Text] [Related]
7. Veno-occlusive disease of the liver after allogeneic bone marrow transplantation in children with hematologic malignancies: incidence, onset time and risk factors. Hasegawa S, Horibe K, Kawabe T, Kato K, Kojima S, Matsuyama T, Hirabayashi N. Bone Marrow Transplant; 1998 Dec; 22(12):1191-7. PubMed ID: 9894723 [Abstract] [Full Text] [Related]
10. Is veno-occlusive disease incidence influenced by the total-body irradiation technique? Belkacémi Y, Ozsahin M, Rio B, Laporte JP, Leblond V, Pène F, Laugier A. Strahlenther Onkol; 1995 Dec; 171(12):694-7. PubMed ID: 8545791 [Abstract] [Full Text] [Related]
11. Does high-dose intravenous immune globulin treatment after bone marrow transplantation increase mortality in veno-occlusive disease of the liver? Klaesson S, Ringdén O, Ljungman P, Aschan J, Hägglund H, Winiarski J. Transplantation; 1995 Dec 15; 60(11):1225-30. PubMed ID: 8525515 [Abstract] [Full Text] [Related]
12. Hepatic veno-occlusive disease post-bone marrow transplantation in children conditioned with busulfan and cyclophosphamide: incidence, risk factors, and clinical outcome. Ozkaynak MF, Weinberg K, Kohn D, Sender L, Parkman R, Lenarsky C. Bone Marrow Transplant; 1991 Jun 15; 7(6):467-74. PubMed ID: 1908340 [Abstract] [Full Text] [Related]
13. Veno-occlusive disease of the liver complicating bone marrow transplantation. Baglin TP. Bone Marrow Transplant; 1994 Jan 15; 13(1):1-4. PubMed ID: 8019444 [Abstract] [Full Text] [Related]
15. Prophylactic low-dose heparin or prostaglandin E1 may prevent severe veno-occlusive disease of the liver after allogeneic hematopoietic stem cell transplantation in Korean children. Song JS, Seo JJ, Moon HN, Ghim T, Im HJ. J Korean Med Sci; 2006 Oct 15; 21(5):897-903. PubMed ID: 17043426 [Abstract] [Full Text] [Related]
18. Ursodiol to prevent hepatic venoocclusive disease. Comcowich SA, Spitzer TR, Tsunoda SM. Ann Pharmacother; 1997 Oct 15; 31(10):1249-52. PubMed ID: 9337452 [Abstract] [Full Text] [Related]
19. [Veno-occlusive disease after bone marrow transplantation: preventive effect of heparin]. Parquet N, Devergie A, Socié G, Ribaud P, Espérou H, Gluckman E. Ann Med Interne (Paris); 1997 Oct 15; 148(2):132-5. PubMed ID: 9238437 [Abstract] [Full Text] [Related]
20. [Veno-occlusive disease of the liver]. Rybicka M, Krysiak R, Okopień B. Wiad Lek; 2009 Oct 15; 62(1):42-51. PubMed ID: 19817257 [Abstract] [Full Text] [Related] Page: [Next] [New Search]